Proteins and Peptides

10 Jul 2007 Roche and Alnylam form major alliance on RNAi therapeutics
10 Jul 2007 Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
06 Jul 2007 Phylogica expands pipeline to acute lung distress
06 Jul 2007 EMEA Approves Kamada’s Plans for Phase II / III Clinical Trials of the Aerosolized Form of AAT for the Treatment of Congenital Emphysema
04 Jul 2007 Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
03 Jul 2007 Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
29 Jun 2007 Merck Serono's fertility treatment Pergoveris(TM) approved in European Union
29 Jun 2007 A 4-Week Therapy with Transition Therapeutics' E1-I.N.T.(TM) Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
29 Jun 2007 OMRIX Biopharmaceuticals Completes Patient Enrollment in Fibrin Patch Phase 1 Clinical Trial
29 Jun 2007 Protalex Reports Clinical Progress of PRTX-100 in Rheumatoid Arthritis and Idiopathic Thrombocytopenic Purpura
28 Jun 2007 Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
28 Jun 2007 Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
28 Jun 2007 Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
27 Jun 2007 ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
26 Jun 2007 Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
26 Jun 2007 PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
26 Jun 2007 Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia
26 Jun 2007 Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
25 Jun 2007 BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
24 Jun 2007 SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
24 Jun 2007 BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
21 Jun 2007 Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
21 Jun 2007 Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up